The atrophy of limb skeletal muscles can lead to decreased limb strength, and if respiratory muscles are affected, it may result in respiratory weakness, increasing the risk of severe complications such as pulmonary infections and respiratory failure in critically ill patients (10)
After analyzing complete trial data from the New England Journal of Medicine and clinical experience managing 340+ patients on GLP-1 and GIP agonists, one pattern emerged: patients who understand the timeline and prepare for peak side effects succeed
Consult Healthcare Providers : Always inform healthcare providers about all medications and supplements being taken to manage potential interactions effectively
Recent updates on GLP-1 agonists: current advancements& challenges
This article has been updated from its original publish date of October 5, 2011
Their cancellation policy is clean (cancel anytime with no contracts or fees) which is a good sign